Skip to Main Content

lexington county

  • sam patrick posted an article
    Lou Kennedy and Nephron Team step up for SC again see more

    Glove Plant Will Shore Up Domestic Supply Chain, Reduce American Dependence on Foreign Sources of Medical-Grade Gloves & Create New Jobs

    WEST COLUMBIA, S.C. – During a celebration attended by strategic partners, business leaders and public officials, Nephron Pharmaceuticals Corporation CEO Lou Kennedy and Governor Henry McMaster today announced the opening of Nephron Nitrile, a plant that will produce American-made, medical-grade nitrile gloves.

    The announcement is the latest Nephron expansion on the sprawling company campus located at Saxe-Gotha Industrial Park in Lexington County.

    Nephron Nitrile – which will be headquartered in more than 400,000 square feet of space in the Kennedy Innovation Complex – represents an investment of more than $100 million in the Midlands. The plant will generate 250 jobs for the area.

    “This is a historic day for our company, and, we believe, for South Carolina,” said Kennedy. “Over the course of the last year, we have poured every bit of creativity, energy and resources we have at our disposal into doing our part, as a proud Made-in-America manufacturer, to respond to an unprecedented crisis. Nephron Nitrile is the latest part of our ongoing effort to make South Carolina the nationwide example for effectively responding to America’s needs, this time by shoring up the domestic supply chain.”

    Kennedy and the governor, along with the entire Nephron team, have made reducing the American dependence on foreign sources of critical health care-related items, such as personal protective equipment (PPE) and lifesaving medications, a top priority. Kennedy joined the governor in April when he announced an executive order to safeguard South Carolina from supply chain disruptions, such as those caused by countries like China, experienced during the COVID-19 pandemic by working to manufacture even more essential, life-saving products in South Carolina.

    Now, just months later, Kennedy and her team at Nephron are stepping up once again. In doing the work on the front end of the announcement to secure partnerships with trusted companies to provide raw materials, machinery and technology, Nephron is in position to make a significant difference in bolstering the PPE supply chain by early 2022.

    “It is critical that South Carolina lead the charge in bringing the production of life-saving medications and supplies back home to the United States,” said Governor McMaster. “After last year’s supply chain disruptions caused by the COVID-19 pandemic, I announced a new initiative aimed at expanding recruitment efforts of pharmaceutical and medical supply manufacturers in the Palmetto State. Nephron Pharmaceuticals Corporation’s continued investment in South Carolina and our people will go a long way toward creating much-needed independence in this industry. This great company continues to show that we have the talent and the ability to do anything we put our minds to, right here in South Carolina.”

    Last July, Kennedy announced an investment of $215 million for Lexington County, bringing 380 new full-time jobs to the area by 2024, and adding new office, warehouse and vaccine production space. This announcement included the establishment of the Kennedy Innovation Complex, home of Nephron Nitrile, and these projects are ahead of schedule. Since re-locating company headquarters to Lexington County from Orlando, Nephron has invested more than a half billion dollars in the region, creating almost 2,000 full and part time jobs.

    “Lexington County is beyond excited to say congratulations again to Nephron Pharmaceuticals,” said Lexington County Council Chairman M. Todd Cullum. “The county is enthusiastic about this announcement as much or more than the company’s original announcement to locate in Lexington County. Their investment in hard assets and jobs is second to none in South Carolina. Nephron’s partnership with Lexington County has been tremendous in helping to improve the quality of life in our county and the region. We can’t wait to see what the future holds for this extraordinary company.”

    A West Columbia, S.C.-based company, Nephron develops and produces safe, affordable generic inhalation solutions and suspension products. The company also operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes, luer-lock vials, IV bottles and IV bags for hospitals across America, in an effort to alleviate drug shortage needs. Nephron launched a CLIA-certified diagnostics lab last year where it tests people for COVID-19 and administers vaccinations.

    For more information regarding Nephron Nitrile, including orders and partnerships, please email: NephronNitrile@nephronpharm.com.

  • sam patrick posted an article
    Nephron, Lexington County businesses step up again see more

    Compliments of Post and Courier Columbia

    WEST COLUMBIA — Nephron Pharmaceuticals CEO Lou Kennedy watched proudly from her office window as a company security guard rushed out to help a woman with a hot pink walker from her vehicle into the West Columbia drug company’s headquarters. 

    Having found the location on the state Department of Health and Environmental Control’s website, the woman was there to receive a COVID-19 vaccine.

    Nephron, along with Cayce-based Dominion Energy and two Lexington County road sign companies, Stay Alert Safety Services and Optec Displays, are donating time and services to put on a free drive-thru vaccine clinic. Eligible participants, age 65 or older, must have an appointment to receive a shot.

    “I’m so proud we can do this,” Kennedy said.

    While the vaccine itself is free, providers are legally able to bill people or their insurance for the doctor or pharmacy visit. Nephron is not charging.

    With about 30 nurses on staff and almost as many doctors of pharmacy, the West Columbia drug maker applied for the certification needed to give the shots and administered its first 500 doses to Lexington County seniors inside its building over the week of Feb. 1.

    It has 1,000 more doses to start giving out on Feb. 8, this time without people having to get out of their vehicles in an effort to make recipients more comfortable, Kennedy said.

    When she first had the idea, she called Keller Kissam, president of electric operations at Dominion Energy South Carolina, to ask if they could use the power company’s vehicle turnaround area. Dominion’s headquarters a 10-minute drive from Nephron.

    “Keller didn’t even hesitate,” Kennedy said. “It was ‘What can we do? How do we help?’ You talk about community spirit.”

    In addition to the drive-thru space, Dominion is providing power to the site to power the computers needed to make appointments for recipients’ second doses. Stay Alert, Optec, as well as the town and county of Lexington are providing signage.

    Those wishing to receive a vaccine from Nephron can go online to DHEC’s website in order to sign up for an appointment.

  • sam patrick posted an article
    $215.8 million investment will create 380 new jobs in Lexington County, SC see more

     Nephron Pharmaceuticals Corporation (Nephron), a global leader in the production of generic respiratory medications and blow-fill-seal contract manufacturing, today announced plans to expand operations in Lexington County. The company's $215.8 million investment will create 380 new jobs.
     
    A West Columbia, S.C.-based company, Nephron develops and produces safe, affordable generic inhalation solutions and suspension products, including those used to treat severe respiratory distress symptoms associated with COVID-19. 
     
    The company also operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes and IV bags for hospitals across America, in an effort to alleviate drug shortage needs. Nephron fills the needs of patients and health care professionals as they arise nationwide, and recently opened a CLIA-certified diagnostics lab.
     
    Headquartered at 4500 12th Street in West Columbia, Nephron’s expansion will add new offices, a new warehouse and production space at its campus in Saxe-Gotha Industrial Park.
     
    The expansion is expected to be completed by Q1 of 2021. Individuals interested in joining the Nephron team should visit https://www.nephronpharm.com/careers

    The Coordinating Council for Economic Development has approved job development credits related to this project.
     
    QUOTES
     
    “The Nephron family is extraordinarily grateful for the opportunity to grow in South Carolina. Thanks to our partnerships with state and local officials, and the trust they have placed in us, we have been able to provide life-saving medications to patients around the world and establish ourselves as the global leader in what we do. We are proud of these achievements and more, and we know our best days are ahead of us. That is what makes this latest announcement so special.” -Nephron Owner & CEO Lou Kennedy
     
    “We are proud to have Nephron Pharmaceuticals in South Carolina. Since coming here they have become an integral part of the community, and recently have been vital in the fight against COVID-19. This new investment of more than $215 million creating 380 new jobs in Lexington County is a great win for Team South Carolina.” -Gov. Henry McMaster
     
    “Nephron is a longtime steward of South Carolina’s business community, and we congratulate them on their continued growth within our state. Today’s announcement is yet another big win for South Carolina, our people and our burgeoning life sciences sector.”  -Secretary of Commerce Bobby Hitt
     
    “We are excited to continue to partner with such an innovative and forward-thinking company like Nephron Pharmaceuticals. We know that Lexington County is a great place to establish and grow a business, and Nephron’s continued success is a testament to good government-business relations.” -Lexington County Council Chairman Scott Whetstone
     
    FIVE FAST FACTS

    •    Nephron Pharmaceuticals Corporation (Nephron) is expanding operations in Lexington County.
    •    The $215.8 million investment is projected to create 380 new jobs.
    •    Nephron is a global leader in the production of generic respiratory medications and blow-fill-seal contract manufacturing.
    •    Headquartered at 4500 12th Street in West Columbia, S.C.
    •    Individuals interested in joining the Nephron team should visit https://www.nephronpharm.com/careers.

  • sam patrick posted an article
    Effort to focus on life sciences, other knowledge-based industries see more

    Compliments of Midlands Biz

    In preparation for an anticipated economic rebound once the effects of the COVID-19 health crisis subside, the Richland County Economic Development Office (RCEDO) has teamed with a group of regional partners to develop an economic development action plan for promoting the growth of knowledge-based industries within the region.

    RCEDO is also collaborating on the plan’s marketing components with those partners, which include Lexington County, the City of Columbia, the University of South CarolinaMidlands Technical College, the S.C. Research Authority (SCRA) and the Central SC Alliance.

    The initiative focuses on five knowledge-based industry segments: information technology/data analytics, financial services, aerospace, medical devices and the biosciences. It is designed to build on existing assets in the region and capitalize on the growing base of research, innovation and industry partnerships at the University of South Carolina.

    “I am exceptionally proud that the entire economic development community in our region has united to ensure that we can more effectively compete to expand the number of knowledge-based jobs,” said Paul Livingston, chair of Richland County Council. “This initiative will have a substantial economic impact on the whole region.”

    The plan also contains a robust marketing component, and RCEDO will collaborate with its regional alliances to implement key strategies. The development office will coordinate with partners to position and promote the Columbia region as a technology and innovation hub.

    “South Carolina is among the most successful states in the nation in building its manufacturing base, but the state has not been as successful in generating jobs in knowledge-based industries,” said Garry Powers, who is overseeing the project for the County as a member of the Economic Development staff.

    “The Columbia metro area has the highest concentration of software-related employment in the state, and bioscience-related companies are expanding rapidly in the region,” said Jeff Ruble, RCEDO director. “Therefore, once we adapt our economic development and workforce programs so that we have an improved capacity to support companies in these targeted industries, the Midlands region is well positioned to substantially increase employment, both within our existing firms and within the new firms that we will attract to the region.”

    As part of this initiative, Deloitte Consulting has analyzed the region’s capacity to grow employment in the targeted industry segments. Using this information, the company developed a detailed action plan that mitigates competitive weaknesses and builds on the region’s strengths.

    To assess the Midlands’ competitive position, Deloitte measured the region’s capacity to support industry expansion compared with more than two dozen other metro areas that are hotbeds of knowledge industry growth.

    Further, the initiative identifies opportunities to improve the region’s competitive position in a variety of areas, including:

    • Enhancing education/training programs based on an analysis of industry needs
    • Expanding programs that build the talent pipeline
    • Ensuring there is sufficient infrastructure (e.g., wet labs, broadband, real estate) to support the targeted industries
    • Restructuring state/local education and training incentives and other state/local incentives to ensure they are competitive nationally

    The SCRA is an active partner in the project because of its mandate to promote the growth of the state’s innovation economy by accelerating technology-enabled growth in research, academia, entrepreneurship and industry. Deloitte’s action plan includes provisions for growing existing small firms and attracting new, innovative small firms within the targeted industry segments. The plan will especially focus on firms capable of building university partnerships.

    The project is expected to provide substantial economic development benefits statewide, and the region has established strong, project-related working relationships with several entities. These include the S.C. Department of Commerce, the State Board for Technical and Comprehensive Education, the S.C. Council on Competitiveness and SCBIO, a statewide, not-for-profit, public–private economic development organization that actively promotes, builds, supports, expands and convenes the state’s life sciences industry.